-
1
-
-
66949164510
-
Advances in stent drug delivery: The future is in bioabsorbable stents
-
Wykrzykowska JJ, Onuma Y, Serruys PW. Advances in stent drug delivery: the future is in bioabsorbable stents. Expert Opin Drug Deliv. 2009;6:113-126.
-
(2009)
Expert Opin Drug Deliv
, vol.6
, pp. 113-126
-
-
Wykrzykowska, J.J.1
Onuma, Y.2
Serruys, P.W.3
-
2
-
-
33847167065
-
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study
-
DOI 10.1016/S0140-6736(07)60314-6, PII S0140673607603146
-
Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667-678. (Pubitemid 46281313)
-
(2007)
Lancet
, vol.369
, Issue.9562
, pp. 667-678
-
-
Daemen, J.1
Wenaweser, P.2
Tsuchida, K.3
Abrecht, L.4
Vaina, S.5
Morger, C.6
Kukreja, N.7
Juni, P.8
Sianos, G.9
Hellige, G.10
Van Domburg, R.T.11
Hess, O.M.12
Boersma, E.13
Meier, B.14
Windecker, S.15
Serruys, P.W.16
-
3
-
-
68249122647
-
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis
-
Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, Gay S, Meier B, Pichler WJ, Juni P, Virmani R, Windecker S. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation. 2009;120:391-399.
-
(2009)
Circulation
, vol.120
, pp. 391-399
-
-
Cook, S.1
Ladich, E.2
Nakazawa, G.3
Eshtehardi, P.4
Neidhart, M.5
Vogel, R.6
Togni, M.7
Wenaweser, P.8
Billinger, M.9
Seiler, C.10
Gay, S.11
Meier, B.12
Pichler, W.J.13
Juni, P.14
Virmani, R.15
Windecker, S.16
-
4
-
-
0029761378
-
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries
-
van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR, Jr., Ellis SG, Topol EJ. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation. 1996;94:1690-1697. (Pubitemid 26320276)
-
(1996)
Circulation
, vol.94
, Issue.7
, pp. 1690-1697
-
-
Van Der, G.W.J.1
Lincoff, A.M.2
Schwartz, R.S.3
Van Beusekom, H.M.M.4
Serruys, P.W.5
Holmes Jr., D.R.6
Ellis, S.G.7
Topol, E.J.8
-
5
-
-
33845879078
-
BioMatrix Biolimus A9-eluting coronary stent: A next-generation drug-elutFing stent for coronary artery disease
-
DOI 10.1586/17434440.3.6.731
-
Grube E, Buellesfeld L. BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease. Expert Rev Med Devices. 2006;3:731-741. (Pubitemid 46017613)
-
(2006)
Expert Review of Medical Devices
, vol.3
, Issue.6
, pp. 731-741
-
-
Grube, E.1
Buellesfeld, L.2
-
6
-
-
53149141718
-
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): A randomised non-inferiority trial
-
Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Davies S, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Juni P. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet. 2008;372:1163-1173.
-
(2008)
Lancet
, vol.372
, pp. 1163-1173
-
-
Windecker, S.1
Serruys, P.W.2
Wandel, S.3
Buszman, P.4
Trznadel, S.5
Linke, A.6
Lenk, K.7
Ischinger, T.8
Klauss, V.9
Eberli, F.10
Corti, R.11
Wijns, W.12
Morice, M.C.13
Di Mario, C.14
Davies, S.15
Van Geuns, R.J.16
Eerdmans, P.17
Van Es, G.A.18
Meier, B.19
Juni, P.20
more..
-
7
-
-
33847705701
-
Stent thrombosis in randomized clinical trials of drug-eluting stents
-
DOI 10.1056/NEJMoa067731
-
Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-1029. (Pubitemid 46376802)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.10
, pp. 1020-1029
-
-
Mauri, L.1
Hsieh, W.-H.2
Massaro, J.M.3
Ho, K.K.L.4
D'Agostino, R.5
Cutlip, D.E.6
-
8
-
-
63149125564
-
Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: A lighthouse and as a toe in the water
-
Vranckx P, Kint PP, Morel MA, Van Es GA, Serruys PW, Cutlip DE. Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: a lighthouse and as a toe in the water. EuroIntervention. 2008;4 Suppl C:C39-44.
-
(2008)
EuroIntervention
, vol.4
, Issue.SUPPL. C
-
-
Vranckx, P.1
Kint, P.P.2
Morel, M.A.3
Van Es, G.A.4
Serruys, P.W.5
Cutlip, D.E.6
-
9
-
-
77955610549
-
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial
-
Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol. 2010;56:272-277.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 272-277
-
-
Wykrzykowska, J.J.1
Garg, S.2
Girasis, C.3
De Vries, T.4
Morel, M.A.5
Van Es, G.A.6
Buszman, P.7
Linke, A.8
Ischinger, T.9
Klauss, V.10
Corti, R.11
Eberli, F.12
Wijns, W.13
Morice, M.C.14
Di Mario, C.15
Van Geuns, R.J.16
Juni, P.17
Windecker, S.18
Serruys, P.W.19
-
10
-
-
34248329889
-
Outcomes and complications associated with off-label and untested use of drug-eluting stents
-
DOI 10.1001/jama.297.18.1992
-
Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007;297:1992-2000. (Pubitemid 46740351)
-
(2007)
Journal of the American Medical Association
, vol.297
, Issue.18
, pp. 1992-2000
-
-
Beohar, N.1
Davidson, C.J.2
Kip, K.E.3
Goodreau, L.4
Vlachos, H.A.5
Meyers, S.N.6
Benzuly, K.H.7
Flaherty, J.D.8
Ricciardi, M.J.9
Bennett, C.L.10
Williams, D.O.11
-
11
-
-
67650755016
-
Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies
-
Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119:3198-3206.
-
(2009)
Circulation
, vol.119
, pp. 3198-3206
-
-
Kirtane, A.J.1
Gupta, A.2
Iyengar, S.3
Moses, J.W.4
Leon, M.B.5
Applegate, R.6
Brodie, B.7
Hannan, E.8
Harjai, K.9
Jensen, L.O.10
Park, S.J.11
Perry, R.12
Racz, M.13
Saia, F.14
Tu, J.V.15
Waksman, R.16
Lansky, A.J.17
Mehran, R.18
Stone, G.W.19
-
12
-
-
0037030658
-
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
-
DOI 10.1056/NEJMoa012843
-
Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780. (Pubitemid 34586912)
-
(2002)
New England Journal of Medicine
, vol.346
, Issue.23
, pp. 1773-1780
-
-
Morice, M.-C.1
Serruys, P.W.2
Eduardo, S.J.3
Fajadet, J.4
Hayashi, E.B.5
Perin, M.6
Colombo, A.7
Schuler, G.8
Barragan, P.9
Guagliumi, G.10
Molnar, F.11
Falotico, R.12
-
13
-
-
75249100540
-
A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial
-
Leon MB, Mauri L, Popma JJ, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, McLaurin BT, Solomon SL, Douglas JS, Jr., Ball MW, Caputo RP, Jain A, Tolleson TR, Reen BM, 3rd, Kirtane AJ, Fitzgerald PJ, Thompson K, Kandzari DE. A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol. 2010;55:543-554.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 543-554
-
-
Leon, M.B.1
Mauri, L.2
Popma, J.J.3
Cutlip, D.E.4
Nikolsky, E.5
O'Shaughnessy, C.6
Overlie, P.A.7
McLaurin, B.T.8
Solomon, S.L.9
Douglas Jr., J.S.10
Ball, M.W.11
Caputo, R.P.12
Jain, A.13
Tolleson, T.R.14
Reen III, B.M.15
Kirtane, A.J.16
Fitzgerald, P.J.17
Thompson, K.18
Kandzari, D.E.19
-
14
-
-
61549097471
-
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: Two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial
-
Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation. 2009;119:680-686.
-
(2009)
Circulation
, vol.119
, pp. 680-686
-
-
Stone, G.W.1
Midei, M.2
Newman, W.3
Sanz, M.4
Hermiller, J.B.5
Williams, J.6
Farhat, N.7
Caputo, R.8
Xenopoulos, N.9
Applegate, R.10
Gordon, P.11
White, R.M.12
Sudhir, K.13
Cutlip, D.E.14
Petersen, J.L.15
-
15
-
-
34248376428
-
Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents
-
DOI 10.1001/jama.297.18.2001
-
Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007;297:2001-2009. (Pubitemid 46740352)
-
(2007)
Journal of the American Medical Association
, vol.297
, Issue.18
, pp. 2001-2009
-
-
Win, H.K.1
Caldera, A.E.2
Maresh, K.3
Lopez, J.4
Rihal, C.S.5
Parikh, M.A.6
Granada, J.F.7
Marulkar, S.8
Nassif, D.9
Cohen, D.J.10
Kleiman, N.S.11
-
16
-
-
51649119808
-
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-Year results from a large 2-institutional cohort study
-
Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Juni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E, Kukreja N, Meier B, Serruys PW, Windecker S. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52:1134-1140.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 1134-1140
-
-
Wenaweser, P.1
Daemen, J.2
Zwahlen, M.3
Van Domburg, R.4
Juni, P.5
Vaina, S.6
Hellige, G.7
Tsuchida, K.8
Morger, C.9
Boersma, E.10
Kukreja, N.11
Meier, B.12
Serruys, P.W.13
Windecker, S.14
-
17
-
-
77649233410
-
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions
-
Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol. 2010;55:1093-1101.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1093-1101
-
-
Serruys, P.W.1
Onuma, Y.2
Garg, S.3
Vranckx, P.4
De Bruyne, B.5
Morice, M.C.6
Colombo, A.7
Macaya, C.8
Richardt, G.9
Fajadet, J.10
Hamm, C.11
Schuijer, M.12
Rademaker, T.13
Wittebols, K.14
Stoll, H.P.15
-
18
-
-
74549129104
-
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: A LEADERS trial sub-study
-
Barlis P, Regar E, Serruys PW, Dimopoulos K, van der Giessen WJ, van Geuns RJ, Ferrante G, Wandel S, Windecker S, van Es GA, Eerdmans P, Juni P, di Mario C. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J. 2010;31:165-176.
-
(2010)
Eur Heart J
, vol.31
, pp. 165-176
-
-
Barlis, P.1
Regar, E.2
Serruys, P.W.3
Dimopoulos, K.4
Van Der Giessen, W.J.5
Van Geuns, R.J.6
Ferrante, G.7
Wandel, S.8
Windecker, S.9
Van Es, G.A.10
Eerdmans, P.11
Juni, P.12
Di Mario, C.13
|